Data / Form D filings / ECM Therapeutics, Inc.
ECM Therapeutics, Inc.: Form D filings
ECM Therapeutics, Inc., a biotechnology company in Warrendale, PA, filed 8 Form D notices with the SEC between 2018 and 2025. The latest, on October 10, 2025, reports $35.2 million sold of a $40 million offering to 190 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 118 MARSHALL DRIVE, Warrendale, PA, 15086
- Phone
- (724) 242-7106
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1743104
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Oct 10, 2025 | Amendment | $40,000,000 | $35,219,000 | $4,781,000 | 190 | May 28, 2018 | sec.gov |
| May 30, 2024 | Amendment | $30,000,000 | $26,100,000 | $3,900,000 | 138 | May 28, 2018 | sec.gov |
| Jun 9, 2023 | Amendment | $25,000,000 | $21,044,006 | $3,955,994 | 182 | May 28, 2018 | sec.gov |
| Sep 14, 2022 | Amendment | $20,000,000 | $15,924,006 | $4,075,994 | 147 | May 28, 2018 | sec.gov |
| Jul 30, 2021 | Amendment | $15,000,000 | $10,091,006 | $4,908,994 | 73 | May 28, 2018 | sec.gov |
| Sep 18, 2019 | Amendment | $10,000,000 | $6,500,000 | $3,500,000 | 73 | May 28, 2018 | sec.gov |
| Jun 18, 2019 | Amendment | $5,000,000 | $2,443,500 | $2,556,500 | 31 | May 28, 2018 | sec.gov |
| Jun 8, 2018 | New notice | $5,000,000 | $919,000 | $4,081,000 | 7 | May 28, 2018 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Paul F. Fagan | Executive Officer, Director | |
| Katie F. Collins | Executive Officer, Director | |
| Christine F. Sheehy | Executive Officer | |
| Jenna F. Dziki | Executive Officer | |
| Stephen F. Badylak | Executive Officer, Director | |
| George F. Hussey | Executive Officer | |
| Lindsey F. Saldin | Executive Officer |
Other biotechnology companies in Pennsylvania that filed recently
- BioLattice Ophthalmics, Inc, $1.8 million · Oct 28, 2026
- Myris Therapeutics, Inc. $500,000 · Oct 14, 2026
- Praeventix, Inc. $5.6 million · Sep 10, 2026
- Plowshare Therapies LLC $6.7 million · Aug 31, 2026
- Noveome Biotherapeutics, Inc. $6.8 million · Aug 27, 2026
- AlloTRx Bio Inc. $500,000 · Aug 24, 2026
Every Form D from the week of Oct 6, 2025 · All recent filings in Pennsylvania · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what ECM Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.